1-3 of 3
Dorian H. LaTocha, BS
Close
Sort by
Journal Articles

Dasatinib Shows Therapeutic Potential in the Murine Xenograft Model for TCF3 rearranged Acute Lymphoblastic Leukemia

Kyle Lenz, Sarah Thompson, Natalya A. Goloviznina, B.S., Jianya Huan, PhD, Dorian H LaTocha, BS, Brian J. Druker, Jeffrey W. Tyner, Peter Kurre, MD, Bill H Chang, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3718.
https://doi.org/10.1182/blood.V124.21.3718.3718
Published: 2014
Journal Articles

Exaggerated Response To Toll-Like Receptor Agonist Contributes To Excessive TNF Production In Myeloproliferative Neoplasm

Angela G. Fleischman, MD, PhD, Samuel B Luty, BS, Michael R Garbati, PhD, J Blair Edmiston, BS, Lacey R Royer, Dorian H LaTocha, BS, Grover C. Bagby, M.D., Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 4097.
https://doi.org/10.1182/blood.V122.21.4097.4097
Published: 2013
Journal Articles

Cryptic Intracellular Retention of ABL Tyrosine Kinase Inhibitors within CML Cells Mediates Apoptosis Commitment Following Acute Drug Exposure,

Thomas O'Hare, Christopher A. Eide, Lauren T. Adrian, Anupriya Agarwal, PhD, Matthew S. Zabriskie, Ryan MacKenzie, BS, Dorian H. LaTocha, BS, Huihong You, PhD, Jenny Luo, BS, Steven M. Riddle, PhD, Bryan Marks, PhD, Dennis R. Koop, PhD, John Apgar, PhD, Michael W. Deininger, Brian J. Druker
Journal: Blood
Blood (2011) 118 (21): 3504.
https://doi.org/10.1182/blood.V118.21.3504.3504
Published: 2011